Repro USMLE step 1 9-6 (9) Flashcards
This patient is young and has no symptoms. She presents for a routine gynecologic examination, and a discrepancy is found in the size of the ovaries. Ultrasound reveals an incidental ovarian mass. This is the general presentation of a Brenner tumor, which is?
a benign ovarian tumor composed of cells that resemble bladder transitional epithelium.
The classic biopsy specimen of a Brenner tumor, as shown in the image, reveals nests of transitional cells (identified by the circles) with coffee bean–shaped nuclei among a fibrous stroma. Epithelial tumors comprise 85% of ovarian tumors, with serous epithelial tumors being the most common epithelial tumor and Brenner tumors being the least common. Other types of epithelial tumors include mucinous, endometrioid, clear cell/mesonephric, and mixed subtypes.
This patient has no symptoms, so some of the other answer options would be incorrect because they are associated with specific symptoms. Meigs syndrome, which is characterized by the classic triad of fibroma, ascites, and hydrothorax, is seen with ovarian fibromas. Ovarian mucinous cystadenomas are associated with a unilateral, multilocular ovarian mass. They can cause bloating, increase in waist size, weight gain, and abdominal pain. Tumors associated with arrhythmias refer to struma ovarii, which can cause symptoms of hyperthyroidism including heat intolerance, tachycardia, diarrhea, and tremor. Tumors that secrete estrogen refer to granulosa cell tumors, which can cause?
endometrial hyperplasia and endometrial carcinomas. Ultrasound examination of this patient did not reveal any endometrial abnormalities.
Brenner tumors are benign ovarian tumors composed of cells that resemble bladder transitional epithelium. They are not as common (or as commonly tested) as?
serous epithelial tumors.
This patient presents with severe abdominal cramping, menorrhagia, and lower back pain correlating with her menstrual cycle. Her symptoms, which have not responded to treatment with oral contraceptives, are classic for endometriosis. Diagnosis would be confirmed by biopsy of the ovarian lesions showing ectopic endometrium.
Ectopic endometrium is estrogen-dependent. Sex hormones are generally produced in response to follicle-stimulating hormone (FSH) and luteinizing hormone (LH), which are controlled by physiologic pulsatile secretion of gonadotropin-releasing hormone (GnRH). Treatment with GnRH agonists like leuprolide or goserelin removes this physiologic pulsation and actually decreases LH/FSH secretion after a short stimulatory period, thereby inhibiting growth of endometrial tissue.
Major adverse effects of GnRH-induced sex hormone depletion include?
osteoporosis and pseudo-menopause (night sweats, hot flashes, etc). Although GnRH agonists are more commonly used, danazol, a synthetic androgen, can also be used to treat endometriosis, Of note, when the ovaries are involved in endometriosis, disease is seen bilaterally in approximately one third of cases.
Heart failure can be an adverse effect of trastuzumab, a monoclonal antibody used to treat HER2-positive breast cancer. Hyperkalemic metabolic acidosis may occur in patients taking spironolactone, a diuretic that is used to treat high blood pressure, heart failure, and edema. (This drug may also be used off-label to treat hirsutism in women with polycystic ovarian syndrome.) Increased uterine cancer risk is seen with estrogen-only supplementation, which may be taken to alleviate?
menopause-related symptoms. Stevens-Johnson syndrome is one adverse effect of aromatase inhibitors, used in the treatment of breast cancer in postmenopausal women.
GnRH agonists such as leuprolide or goserelin can be used for treatment of endometriosis-related pelvic pain. They act by decreasing LH/FSH secretion after a short stimulatory period. Adverse effects of sex hormone depletion include?
osteoporosis and pseudo-menopause. Danazol can also be used to treat endometriosis, but GnRH agonists are more commonly used.
A woman presents to the physician’s office with red, ring-like lesions on her body that appeared after using the yoga mats at her local gym.
Given these findings, the most likely diagnosis is tinea corporis, commonly known as “ringworm.” Tinea corporis is a fungal skin infection that is seen in athletes who play close-contact sports or use improperly cleaned sports equipment (in this case, yoga mats). Lesions are pruritic, erythematous, scaly, and demonstrate central clearing.
Mild tinea corporis can be treated with topical antifungals, but systemic therapy, such as ?
ketoconazole, is preferred for more extensive skin involvement. Ketoconazole acts by blocking the formation of fungal membrane steroids.
In addition, the drug inhibits the enzymes desmolase/CYP450scc and 17-a-hydroxylase. Inhibition of 17-a-hydroxylase contributes to ketoconazole’s antiandrogenic effects, which include decreased libido, impotence, and gynecomastia in men. This patient’s darkening skin is a result of the desmolase inhibition. Desmolase is necessary for adrenal production of testosterone and cortisol. Free cortisol is responsible for feedback inhibition of the POMC gene, which codes for synthesis of ACTH, lipotropin, melanocyte-stimulating hormone, and some endogenous endorphins. With decreased cortisol levels, this feedback inhibition is removed and the POMC gene products are freely transcribed. This, in turn, leads to excessive melanocyte-stimulating hormone which can cause increased integumentary pigmentation, similar to the hyperpigmentation seen in Addison disease and which is seen in the darkened patches on this patient’s skin.
Amphotericin B and flucytosine are not used in the treatment of tinea corporis. Both fluconazole and itraconazole are not associated with?
endocrine side effects and would not cause the skin darkening seen with ketoconazole.
Desmolase inhibition by ketoconazole results in reduced levels of circulating adrenal steroid hormones. Without free cortisol to feedback-inhibit ACTH, POMC gene products including melanocyte-stimulating hormone are freely transcribed; this leads to the skin darkening sometimes seen with?
ketoconazole use.
This young child has significant hepatosplenomegaly and progressive widespread neurodegeneration (as evidenced by his failure to hit developmental milestones). Fundoscopic examination shows a cherry-red spot on the macula (first image). The combination of these symptoms and findings suggest a diagnosis of Niemann-Pick disease.
Niemann-Pick disease is caused by the absence of the enzyme sphingomyelinase which converts ?
sphingomyelin to ceramide. The deficiency of sphingomyelinase in patients with Niemann-Pick disease causes accumulation of sphingomyelin and cholesterol in parenchymal and reticuloendothelial cells. Under a light microscopy, these lipid-laden macrophages have a foamy appearance, which is consistent with the findings on the bone marrow biopsy examination. The foamy appearance is caused by the presence of innumerable small vacuoles of relatively uniform size.
Fabry disease is caused by a mutation of a-galactosidase A which converts ceramide trihexoside to lactosyl cerebroside. It manifests in early childhood with peripheral neuropathy, angiokeratomas (tiny painless papules), renal insufficiency and cardiovascular disease (not seen in our patient).
Krabbe disease is caused by a mutation in galactocerebrosidase which converts ?
galactocerebroside to ceramide. Patients with this disease develop optic atrophy (not a cherry-red macula spot), peripheral neuropathy, and developmental delay.
Tay-Sachs disease and Niemann-Pick have a similar clinical presentation of progressive neurological decay with a cherry-red spot on the macula. Tay-Sachs is caused by a lack of ß-hexosaminidase A which converts ganglioside M2 to ganglioside M3. The key distinguishing feature is the lack of hepatosplenomegaly in Tay-Sachs disease.
Lastly, Gaucher disease is caused by?
a lack of ß-glucocerebrosidase which converts glucocerebroside to ceramide. While patients with Gaucher disease may have hepatosplenomegaly, the other symptoms of skeletal weakness, pathologic fractures and bruising (because of thrombocytopenia) are absent in this patient.
Niemann-Pick disease is caused by a lack of the enzyme sphingomyelinase which converts ?
sphingomyelin to ceramide. It is characterized by neurodegeneration, a cherry-red spot on the macula, foam cells, and notably, hepatosplenomegaly (which distinguishes this disease from Tay-Sachs disease).
This sexually active patient with a painless ulcerative lesion on his penis most likely has primary syphilis caused by Treponema pallidum. Venereal Disease Research Laboratory (VDRL) titers and fluorescent treponemal antibody absorption (FTA-ABS) testing may be used to confirm the diagnosis.
Syphilis is categorized by the following stages:
Primary syphilis: In men, this stage is characterized by?
a painless chancre, usually on the penis, which develops about 3 weeks after exposure. Women with primary syphilis may appear to be free of symptoms because the chancre may develop in the vagina or rectum.
Secondary syphilis: This disseminated stage of the disease develops within 4 to 10 weeks after primary infection and may manifest with a maculopapular rash, condyloma lata, lymphadenopathy, hair loss, muscle aches, fever, sore throat, and swollen lymph nodes. A latent, asymptomatic stage may follow and last for years.
Tertiary syphilis develops late in about 40% of patients who have gone untreated. It is characterized by ?
subcutaneous granulomas (gummas). Although neurosyphilis can occur at any time after initial infection, it is more likely to present with tertiary syphilis and manifest with dementia, personality changes, and posterior spinal cord degeneration (tabes dorsalis).
Note that symptoms are generally associated with a single stage but may also overlap.
Syphilis is treated with penicillin G.